View in EDS HTML Full Text PDF Full Text

Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma.

Saved in:
Bibliographic Details
Title: Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma.
Authors: Than, Minh T.1,2 (AUTHOR), Dequiedt, Lucie3 (AUTHOR), Sor, Rina2 (AUTHOR), Nair, Shreya1,2 (AUTHOR), Markosyan, Nune1,2 (AUTHOR), Furth, Emma E.4 (AUTHOR), Yang, Chenghua2 (AUTHOR), Ray-Fofana, Courtney2 (AUTHOR), Menard, Marie5 (AUTHOR), Quintana, Elsa5 (AUTHOR), Edwards, A. Cole2 (AUTHOR), Hennessey, Connor J.2 (AUTHOR), Good, Austin L.2 (AUTHOR), Quinones, Liz2 (AUTHOR), Hwang, Yunseo3 (AUTHOR), Clendenin, Cynthia2 (AUTHOR), Kiemen, Ashley L.3,6,7,8 (AUTHOR), Vonderheide, Robert H.1,2 (AUTHOR) rhv@upenn.edu, Stanger, Ben Z.1,2 (AUTHOR) bstanger@upenn.edu
Source: Science. 3/12/2026, Vol. 391 Issue 6790, p1161-1166. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00368075
DOI:10.1126/science.aec7929